Stem Cell Doctors from India and Stem Cell Options – Video

Stem Cell Doctors from India and Stem Cell Options
Review stem cell doctors and stem cell nutrition options from India ..www.EJrecommends.com .. then investigate how your own bone marrow stem cells help repair aging and damaged tissues, muscles, bones ,hearts and other organs. Many stem cell procedures are performed in India, and other international countries. Some adult stem cell releasing.. extracting .. and stem cell injection procedures are performed in the USA. Investigate all your stem cell nutrition options.. including Naturally Releasing 3 to 4 MILLION more Stem Cells from your Bone Marrow within 60 MINUTES of consuming 2 patented adult stem cell nutrition capsules. Investigate a proactive wellness lifestyle by releasing MILLIONS more of YOUR OWN adult stem cells from your bone marrow EVERY DAY with adult stem cell nutrition capsules. Your body is indeed a Miracle.. and your own adult stem cells constitute Your body #39;s own RENEWAL SYSTEM to help in anti-aging and rejuvenation of not only your heart .. but ALL your organs, tissues and muscles. See VIDEO of patented stem cell nutrition including capsules, tablets granules, powders and serums.. httpFrom:EJ MorrisViews:30 0ratingsTime:04:34More inScience Technology

Read more here:
Stem Cell Doctors from India and Stem Cell Options - Video

Stem Longevity Research Links with BioProtein Technology – Renowned Partnership to Elevate Brand’s Innovative …

BioProtein Technology, a company that manufactures therapeutic proteins in the form of growth factors, has announced an alliance with Stem Longevity Research, a company partnered by Dr. Joseph Purita and CNC Reid Eckert.

(PRWEB) October 15, 2012

Stem Longevity Research has expertise in the medical applications of stem cells. Dr. Purita and Eckert will offer their high level of credibility to increase the exposure of BioProtein Technology's products on the part of physicians across the United States.

We are thrilled to welcome Dr. Purita and Reid Eckert to our team, as they are among the world's most respected stem cell researchers, said Paul Morave, National Sales Director for BioProtein Technology. With their endorsement of our products, we immediately gain a tremendous level of credibility in the eyes of doctors and medical professionals. Were very excited to begin our work with Stem Longevity Research and are looking forward to leveraging the knowledge they bring to our company.

Dr. Joseph Purita is one of the pioneers of PRP and stem cell injection research. His passion for stem cell research has helped him create the Institute of Regenerative and Molecular Orthopedics, where the standard is set for orthopedic stem cell treatments. Doctors from all over the world train in the use of PRP and stem cell treatment with Dr. Purita at the Institute.

Eckert specializes in the treatment of diseases and disorders for people of all ages. He is a certified nutritional counselor who is dedicated to bringing nutritional education and quality of life to those suffering from health challenges. Eckert also currently serves as a medical advisor for InHealth Media, a media and marketing firm that works with brands in the nutraceutical and sports nutrition industries.

BioProtein Technology offers a family of natural treatment therapies that combine the effective concepts of traditional medicine with modern technological breakthroughs. The company differentiates itself by dedicating unparalleled time and energy into a single raw material, giving its team complete top-down control of the manufacturing process.

The BioProtein Technology product line includes Velvet Antler Extract, which promotes anti-aging and naturally supports healthy cell regeneration and repair. This product balances hormones, modulates endocrine and immune systems and improves memory and cognition, among many other benefits. Other products include natural hormone and immune modulator Sub-L Tropin, topical anti-inflammatory solution Derma-T Tropin and Derma-T Tropin, an anti-aging skin care solution.

Its an honor to join the team of BioProtein Technology, a company that is doing groundbreaking work in creating top-quality alternative treatment products, said Eckert. Our goal is to significantly increase physicians awareness of this brand and the numerous benefits these products offer to individuals. Were very pleased to take part in what BioProtein Technology is doing for both doctors and their patients.

Stem Longevity Researchs work with BioProtein Technology will begin effective immediately. For more information, visit http://www.bioproteintech.com.

Link:
Stem Longevity Research Links with BioProtein Technology - Renowned Partnership to Elevate Brand’s Innovative ...

Japan, UK scientists win Nobel for stem cell breakthroughs

STOCKHOLM: Scientists from Britain and Japan shared the Nobel Prize in Medicine on Monday for the discovery that adult cells can be reprogrammer back into stem cells which can turn into any kind of tissue and may one day repair damaged organs. John Gurdon, 79, of the Gurdon Institute in Cambridge, Britain and Shinya Yamanaka, 50, of Kyoto University in Japan, discovered ways to create tissue that would act like embryonic cells, without the need to harvest embryos. They share the $1.2 million prize equally. These groundbreaking discoveries have completely changed our view of the development and specialization of cells, the Nobel Assembly at Stockholms Karolinska Institute said in a statement. The big hope for stem cells is that they can be used to replace damaged tissues in everything from spinal cord injuries to Parkinsons disease. All of the tissue in the body starts as stem cells, before developing into mature skin, blood, nerves, muscle and bone. Scientists once thought it was impossible to turn adult tissue back into stem cells, which meant that new stem cells could only be created by harvesting embryos. But Yamanaka and Gurdon showed that development can be reversed, turning adult cells back into cells that behave like embryos. With induced pluripotency stem cells, or iPS cells, ordinary skin or blood cells from adults are transformed back into stem cells which doctors hope will be able to repair damaged organs without being rejected by the immune system. There are concerns, however, that iPS cells could grow out of control and develop into tumors. The eventual aim is to provide replacement cells of all kinds, Gurdons Institute explains on its website. We would like to be able to find a way of obtaining spare heart or brain cells from skin or blood cells. The important point is that the replacement cells need to be from the same individual, to avoid problems of rejection and hence of the need for immunosuppression. Gurdon discovered in 1962 that the specialization of cells could be reversed. In what the prize committee called a classic experiment, he replaced the immature cell nucleus in an egg cell of a frog with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole, proving that the mature cell still had all the information needed to develop all cells in the frog. More than 40 years later, in 2006, Yamanaka discovered how intact mature cells in mice could be reprogrammer to become stem cells by adding just a few genes. Thanks to these two scientists, we know now that development is not strictly a one-way street, said Thomas Perlmann, Nobel Committee member and professor of Molecular Development Biology at the Karolinska Institute. There is lot of promise and excitement, and difficult disorders such as neurodegenerative disorders, like perhaps Alzheimers and, more likely, Parkinsons disease, are very interesting targets.

Read the original here:
Japan, UK scientists win Nobel for stem cell breakthroughs

UK, Japan scientists win Nobel for stem cell breakthroughs

STOCKHOLM (Reuters) - Scientists from Britain and Japan shared the Nobel Prize in Medicine on Monday for the discovery that adult cells can be reprogrammed back into stem cells which can turn into any kind of tissue and may one day repair damaged organs.

John Gurdon, 79, of the Gurdon Institute in Cambridge, Britain and Shinya Yamanaka, 50, of Kyoto University in Japan, discovered ways to create tissue that would act like embryonic cells, without the need to harvest embryos. They share the $1.2 million prize equally.

"These groundbreaking discoveries have completely changed our view of the development and specialisation of cells," the Nobel Assembly at Stockholm's Karolinska Institute said in a statement.

The big hope for stem cells is that they can be used to replace damaged tissues in everything from spinal cord injuries to Parkinson's disease.

All of the tissue in the body starts as stem cells, before developing into mature skin, blood, nerves, muscle and bone.

Scientists once thought it was impossible to turn adult tissue back into stem cells, which meant that new stem cells could only be created by harvesting embryos. But Yamanaka and Gurdon showed that development can be reversed, turning adult cells back into cells that behave like embryos.

With "induced pluripotency stem cells", or iPS cells, ordinary skin or blood cells from adults are transformed back into stem cells which doctors hope will be able to repair damaged organs without being rejected by the immune system.

There are concerns, however, that iPS cells could grow out of control and develop into tumours.

"The eventual aim is to provide replacement cells of all kinds," Gurdon's Institute explains on its website.

"We would like to be able to find a way of obtaining spare heart or brain cells from skin or blood cells. The important point is that the replacement cells need to be from the same individual, to avoid problems of rejection and hence of the need for immunosuppression."

See original here:
UK, Japan scientists win Nobel for stem cell breakthroughs

Fund-raising gives hope for Georgia

Buy photos Katie Mander, customer advisor, with Paul Ballantyne, manager, Hayley Jepson, business manager and Natalie Naughton with Georgia Almquest. Picture by Neville Collins. 40012037ncb1 http://www.buyphotos247.com

MORE THAN 8,000 has already been raised for the Hope for Georgia campaign which is aimed at sending Bromsgrove girl Georgia Almquest to America for revolutionary stem cell treatment.

Georgia, who is two-years-old next Saturday (October 13), has cerebral palsy, which means she is unable to hold her head up, sit or crawl. The stem cell procedure, which will cost 20,000, will improve her quality of life and, doctors have said, is her only chance of walking.

Almost 4,000 of the total was raised at a funday at The Sugarbrook pub in Charford, which took place on Saturday (September 29). That had a variety of activities, including a tombola, raffle and people doing sponsored events, such as waxes.

Georgia's mum Natalie said: "It was an amazing event - everyone was giving really generously and getting into the spirit of the day.

"There were even adults having their faces painted.

"I can't believe how much has been raised so far in a matter of weeks."

She thanked everyone who has contributed so far and the Bromsgrove branch of the Halifax bank which has collected more than 400 for the appeal. That cash was raised from a quiz and Irish bingo which took place at the Hanbury Turn. Prizes, included a signed Leicester Tigers rugby shirt, donated by Jordan Crane, a luxury fruit and wine hamper and an M&S gift voucher. The event raised 203.13, but with the bank matching the funding, the total will be 406.26.

Katie Mander, from the Bromsgrove branch of Halifax, organised the event.

She said: "I am very pleased that this money can go to such a good cause - Georgia will get to her 20,000 target with the help of everyone in Bromsgrove."

Go here to read the rest:
Fund-raising gives hope for Georgia

Stem cells could lead to future fertility treatments, study says

In a long-sought achievement, Japanese researchers have demonstrated in mice that both eggs and sperm can be grown from stem cells and combined to produce healthy offspring, pointing the way to a new avenue for fertility treatments.

If the milestone accomplishment can be repeated in humans -- and experts said they are optimistic that such efforts will ultimately succeed -- the technique could make it easier for women in their 30s or 40s to become mothers. It could also help men and women whose reproductive organs have been damaged by cancer treatments or other causes.

About 10% of American women of childbearing age have trouble becoming or staying pregnant, and more than one-third of infertile couples must contend with a medical problem related to the prospective father, according to the U.S. Centers for Disease Control and Prevention in Atlanta.

Using current technology, only about one-third of attempts at assisted reproduction result in live births, CDC data show. Scientists, doctors and patients would like to boost that percentage.

"These studies provide that next level of evidence that in the future fertility could be managed with stem cell intervention," said Teresa Woodruff, chief of fertility preservation at Northwestern University's Feinberg School of Medicine.

The prospect of using stem cells to grow new eggs is particularly tantalizing, because women are born with a set amount and don't make more once they are lost. In a sense, the therapy would allow them to turn back their biological clocks, said Stanford stem cell researcher Renee A. Reijo Pera, who studies reproduction.

"This is a get-them-back strategy," she said.

Using stem cells to create sperm and eggs in mice is a feat researchers have attempted, without much success, for more than a decade, said Dr. George Q. Daley, a leading stem cell researcher at Children's Hospital in Boston.

Dr. Mitinori Saitou and colleagues at Kyoto University detailed how they generated the functional mouse eggs in a report published online Thursday by the journal Science. Last year, the researchers reported in the journal Cell that they had done the same thing with mouse sperm.

In both cases, the team started with embryonic stem cells, which have the potential to develop into all of the different types of cells in the body. The scientists exposed the embryonic stem cells to stimuli that coaxed them to become egg and sperm precursors.

Read the rest here:
Stem cells could lead to future fertility treatments, study says

Mouse stem cells used to produce eggs, Japanese scientists say

Reaching a long-sought milestone, Japanese researchers have demonstrated in mice that eggs and sperm can be grown from stem cells and combined to produce healthy offspring, pointing the new treatments for infertility.

If the achievement can be repeated in humans and experts said they are optimistic that such efforts will ultimately succeed the technique could make it easier for women in their 30s or 40s to become mothers. It could also help men and women whose reproductive organs have been damaged by cancer treatments or other causes.

About one in 10 American women of childbearing age have trouble becoming or staying pregnant, and more than one-third of infertile couples must contend with a medical problem related to the prospective father, according to the national Centers for Disease Control and Prevention in Atlanta.

Using current technology, only about one-third of attempts at assisted reproduction result in live births, CDC data show. Scientists, doctors and patients would like to boost that percentage.

"These studies provide that next level of evidence that in the future fertility could be managed with stem cell intervention," said Teresa Woodruff, chief of fertility preservation at Northwestern University Feinberg School of Medicine.

The prospect of using stem cells to grow new eggs is particularly tantalizing, since women are born with a set number and don't make more once they are gone. In a sense, the therapy would allow them to turn back their biological clocks, said Stanford stem cell researcher Renee A. Reijo Pera, who studies reproduction.

"This is a get-them-back strategy," she said.

Dr. Mitinori Saitou and colleagues at Kyoto University detailed how they generated the functional mouse eggs in a report published online Thursday by the journal Science. Last year, the researchers reported in the journal Cell that they had done the same thing with mouse sperm.

In both cases, the team started with embryonic stem cells, which have the potential to develop into all of the different types of cells in the body.

The scientists exposed the embryonic stem cells to stimuli that coaxed them to become egg and sperm precursors.

View post:
Mouse stem cells used to produce eggs, Japanese scientists say

Todd Akin’s ‘War on Women’ Started Seven Years Ago

Rep. Todd Akin, R-Mo., ignited a firestorm Aug. 19 when he claimed women who are the victims of "legitimate rape" biologically don't carry a baby to term. Voters in Missouri had a heads-up moment seven years ago when Akin made an ultra-conservative speech on the floor of Congress regarding embryonic stem cell research. Three years later, the representative made odd remarks about abortion doctors.

Akin's so-called "war on women" didn't begin in August. It may have started seven years ago.

What exactly did Akin say on the floor of the House of Representatives?

Slate.com found two videos of the representative speaking before his fellows in Congress. In May 2005, Akin slammed embyronic stem cell research. The representative claimed to be telling a story his daughter wrote about how a child is named "5-25-61-B" instead of a human name. Akin further likened a mother's womb to "climate control" for the "unique information that defines a person."

A second video Slate found on C-SPAN was from January 2008. Akin slammed abortion doctors as people who have a "culture of death" along with "all kinds of other law-breaking: not following good sanitary procedure, giving abortions to women who are not actually pregnant, cheating on taxes misuse of anesthetics so that people die or almost die."

What has been the reaction to these videos?

Dan Amira of New York Magazine found a Chicago Tribune story that seems to corroborate Akin's testimony on abortion doctors . Arnold Bickham had his license revoked for 18 months beginning in 1979 for performing abortions on women "not pregnant and sometimes not fully under anesthesia."

The Slate article notes Akin or his daughter may have read a book entitled "Never Let Me Go ." The novel focuses on children who grow up to be clones designed to be harvested for their organs. The piece, written in 2005, is by Kazuo Ishiguro. Akin's speech denouncing cloning and stem cell research was made the same year "Never Let Me Go" was published.

How do these new revelations change the Missouri Senate race?

Slate published an article Tuesday evening regarding Akin's chances of winning the statewide vote. Despite his comments, voter Dee Eukel supports Akin even though she was the victim of rape. Eukel told the media outlet, "I understand [legitimate rape] because I was a victim. And our local prosecutor told me: We best accept a plea bargain because we can't get a prosecution on rape."

Continue reading here:
Todd Akin’s ‘War on Women’ Started Seven Years Ago

Celltex To Initiate New Clinical Program As It Responds To FDA Letter

HOUSTON, Oct. 1, 2012 /PRNewswire/ --Celltex Therapeutics Corp. announced today that it has received a letter, dated Sept. 24, 2012, from the U.S. Food and Drug Administration. The letter stated the agency's opinion that the process Celltex uses to multiply adult stem cells is subject to FDA regulation as biological drug manufacturing. The issue is a key one as stem cell therapy for patient care outside of an academic institution is a new frontier, yet there are a variety of technologies being used throughout the United States, often creating complex legal and regulatory questions.

David Eller, CEO and President of Celltex, stated:

Celltex makes identical copies of an individual's own stem cells and therefore should not be subject to FDA regulation as drugs. However, the FDA said our process causes the cells to be considered biological drugs and thus is subject to those regulations. We respectfully but firmly disagree with the FDA and intend to contest the agency's opinion within its administrative procedures. We are considering all options as we work with the agency toward a resolution.

FDA's letter also repeats its earlier observations from an April inspection of Celltex's laboratory. While Celltex provided detailed responses in April, May, June, July and August, now FDA tells us it needs more information. We will answer FDA's questions in whatever detail the agency requests."

We will meet FDA's requirements, no matter how high the hurdles may be, to ensure access to this technology. Celltex remains fully committed to advance the most promising new field in human health in decades regenerative medicine. We also remain committed to doing so safely, and we will continue to comply with federal and state agency requirements.

As we work with the FDA, Celltex will continue to make advances on the frontier of regenerative medicine, and we expect to have several significant announcements in the coming weeks on these matters:

"Celltex is committed to developing the promise of regenerative medicine into a reality for doctors and their patients," Mr. Eller said. "We sponsor clinical trials to better understand the therapeutic impact and monitor the safety of adult stem cell therapy, and we are confident that our research will help implement effective treatments for patients suffering from a variety of medical conditions."

For more information on Celltex Therapeutics Corporation and its staff please visit http://www.CelltexBank.com.

About Celltex

Celltex Therapeutics Corporation is a leader in providing services for the rapidly expanding field of regenerative medicine.Specifically, Celltex purifies, multiplies, and stores adult adipose-derived mesenchymal stem cells and rigorously follows the standards of good manufacturing practices for human cell laboratories. Celltex's laboratory currently holds more than fourteen patents protecting methodology and quality control. The Celltex process ensures extracted adult stem cells are separated, multiplied and stored without any genetic alteration or exposure to stimulants to alter the cells' natural multiplication ability. Celltex is currently researching new methods and technology for banking and stem cell treatment therapies to further the field of regenerative medicine and document the therapeutic impact of adult stem cell therapies on various medical conditions.

See the original post:
Celltex To Initiate New Clinical Program As It Responds To FDA Letter

Coffee sale raises $30,000 for Spokane woman’s stem cell transplant

by KREM.com

KREM.com

Posted on October 1, 2012 at 11:43 AM

Updated today at 1:53 PM

Spokane -- A local woman fighting for her life will receive more than $30,000 in community donations thanks to a fundraiser held over the weekend by Dutch Bros. Spokane.

The coffee company offered drinks for $2 Saturday, and owners donated $1 of each sale to Davis for a potentially life-saving stem cell transplant.

The 24-year-old suffers from CREST syndrome, an acronym for five diseases that have a long list rehabilitating symptoms. Cat has tried many things to cure the disease, but nothing has worked. Doctors say she has months to live, and she needs a stem cell treatment as soon as possible. If her organs harden too much, she will no longer be a candidate for the treatment.

San Francisco Giants pitcher Jeremy Affeldt, who hails from Spokane, pledged to match funds raised by Saturdays fundraiser.

The Cure for Cat Foundation hopes to raise $125,000 for the stem cell treatment.

Here is the original post:
Coffee sale raises $30,000 for Spokane woman’s stem cell transplant